全文获取类型
收费全文 | 27427篇 |
免费 | 2450篇 |
国内免费 | 934篇 |
专业分类
耳鼻咽喉 | 212篇 |
儿科学 | 977篇 |
妇产科学 | 144篇 |
基础医学 | 3572篇 |
口腔科学 | 384篇 |
临床医学 | 1934篇 |
内科学 | 6796篇 |
皮肤病学 | 1866篇 |
神经病学 | 288篇 |
特种医学 | 1034篇 |
外科学 | 3480篇 |
综合类 | 3661篇 |
现状与发展 | 3篇 |
预防医学 | 1075篇 |
眼科学 | 156篇 |
药学 | 2862篇 |
9篇 | |
中国医学 | 1771篇 |
肿瘤学 | 587篇 |
出版年
2024年 | 48篇 |
2023年 | 621篇 |
2022年 | 762篇 |
2021年 | 1086篇 |
2020年 | 1183篇 |
2019年 | 1122篇 |
2018年 | 1119篇 |
2017年 | 1160篇 |
2016年 | 1020篇 |
2015年 | 1129篇 |
2014年 | 1751篇 |
2013年 | 1995篇 |
2012年 | 1626篇 |
2011年 | 1766篇 |
2010年 | 1474篇 |
2009年 | 1401篇 |
2008年 | 1484篇 |
2007年 | 1384篇 |
2006年 | 1208篇 |
2005年 | 1043篇 |
2004年 | 832篇 |
2003年 | 635篇 |
2002年 | 570篇 |
2001年 | 513篇 |
2000年 | 399篇 |
1999年 | 361篇 |
1998年 | 308篇 |
1997年 | 246篇 |
1996年 | 242篇 |
1995年 | 233篇 |
1994年 | 232篇 |
1993年 | 181篇 |
1992年 | 149篇 |
1991年 | 120篇 |
1990年 | 127篇 |
1989年 | 97篇 |
1988年 | 103篇 |
1987年 | 105篇 |
1986年 | 96篇 |
1985年 | 102篇 |
1984年 | 100篇 |
1983年 | 51篇 |
1982年 | 93篇 |
1981年 | 82篇 |
1980年 | 72篇 |
1979年 | 57篇 |
1978年 | 45篇 |
1977年 | 43篇 |
1976年 | 42篇 |
1974年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
目的 通过分析特发性肺纤维化急性加重期(AE-IPF)患者证候与血清生物标志物的关系,为中医辨证治疗提供参考。方法 采用观察性研究设计,收集2019年3月至2019年11月三个中心的AE-IPF患者76例,其中痰热壅肺证26例、痰浊阻肺证50例,并纳入健康志愿者10例作为对照。采用ELISA测定患者血清CCL18、HMGB1、KL-6、MMP-7、SP-A和SP-D水平,分析与中医证候的相关性。结果 AE-IPF患者血清CCL18、HMGB1、KL-6、MMP-7、SP-A和SP-D水平均显著高于健康对照组。血清CCL18、HMGB1、KL-6、MMP-7和SP-D水平在痰热壅肺证和痰浊阻肺证患者间无显著性差异(P>0.05),而血清SP-A水平存在显著性差异(P<0.05)。结论 血清SP-A与AE-IPF证候存在一定的相关性,血清SP-A的浓度升高,与痰热壅肺证关系越密切,反之,血清SP-A浓度降低,则与痰浊阻肺证关系越密切。AE-IPF痰热壅肺证患者的预后可能较痰浊阻肺证患者更差。 相似文献
3.
Efficacy of Curcumin in Combination with Intralesional Dexamethasone with Hyaluronidase in the Treatment of Oral Submucous Fibrosis: A Randomized Controlled Trial 下载免费PDF全文
Sagar AdhikariJyotsna RimalIccha Kumar MaharjanAshish Shrestha 《Asian Pacific journal of cancer prevention》2022,23(9):3125-3132
Objective: The objective of this study was to determine the efficacy of curcumin in combination with intralesional dexamethasone with hyaluronidase in the treatment of oral submucous fibrosis (OSF). Methods: This randomized, double blind, parallel design, clinical trial was conducted at B.P. Koirala Institute of Health Sciences, Nepal. Thirty-four patients with clinically diagnosed OSF were randomized into two groups (17 participants in each) with baseline treatment of intralesional dexamethasone with hyaluronidase for 6 weeks for the both. Curcumin (2gm/day) was provided to Group A (Test) and Group B (Control) received placebo. Interincisal mouth opening, tongue protrusion, cheek flexibility and visual analogue scale (VAS) scoring of burning sensation of oral mucosa was recorded at baseline, 6, 8 and 12 weeks follow-up and independent t-test was used to compare the improvements in two groups. Results: On comparing the 6 weeks and baseline values, in Group A and B the mean difference in mouth opening was 8.82±1.33 mm and 5.53±1.17 mm respectively (p<0.001), in cheek flexibility was 2.94±1.02 mm and 1.94±1.24 mm respectively (p=0.02) and in tongue protrusion was 6.23±1.48 and 3.65±1.37 mm respectively (p<0.001). The findings were consistent in the 8 weeks follow-up. In 12 weeks follow-up, on comparing with the baseline values, in Group A and B, the mean difference in mouth opening was 8.71±1.16 mm and 5.35±1.22 mm respectively (<0.001), ), in cheek flexibility was 2.81±1.01 mm and 1.76±1.35 mm respectively (p=0.02) and in tongue protrusion was 6.06±1.48 and 3.35±1.50 mm respectively (p<0.001). Both the arms showed 100% improvement in burning sensation in 6, 8 and 12 weeks follow-up. Conclusion: Curcumin in combination with intralesional dexamethasone with hyaluronidase is efficacious in the treatment of OSF. 相似文献
4.
《Indian journal of medical microbiology》2022,40(4):593-595
The performance of enzyme linked immunosorbent assays (EAST) for identifying six indoor allergens was evaluated using skin prick test (SPT) as reference tests in 154 children with allergic rhinitis. Sensitivity of EAST ranged from 9% (cat) to 54% (HDM) with specificity of 74%(cockroach) to 100% (cat) with an agreement ranged from 58 to 86%. Cut off values ?> ?0.35 kU/L showed best sensitivity and specificity. Our findings agree with extant literature which suggests that the ability of EAST to determine the precipitating allergen is moderate. Assays for definitively identifying the inhalant allergen are currently not available. 相似文献
5.
目的 对中医药治疗特发性肺纤维化(idiopathic pulmonary fibrosis, IPF)的系统评价(SRs)进行再评价。方法 检索知网、中国生物医学数据库、维普、万方、The Cochrane Library、Web of Science、PubMed和EMbase数据库,纳入中医药治疗IPF的SRs,截止2021年5月。使用AMSTAR 2量表进行方法学质量评价,GRADE系统工具进行结局指标证据质量分级。结果 共纳入28篇文献,试验组除辨证论治外,治疗方法集中在活血化瘀、补肺益气等方面,基本符合治疗法则。结果显示中医药治疗IPF可以提高有效率、增加肺功能、提高PaO2、增加6WMD、缓解临床症状、提高患者的生活质量等。AMSTAR 2量表评价,所纳入SRs均有多项关键条目不达标,整体方法学质量等级不高。采用GRADE工具进行质量分级,一共234个结局指标,无高等证据质量,整体证据等级不高。结论 中医药对比西医治疗IPF有效且不良反应不明显,但RCT研究和系统评价研究方法质量尚有缺陷,完全按照西医评价指标可能会低估真实结果,未来需要更规范的研究及适合中医的评价指标,对中医药研究的安全性方面关注还有待提高。 相似文献
6.
7.
8.
There is now increased knowledge and experience of newborn screening around the world. There is also a better understanding of CF gene analysis, informed by international databases. This has resulted in a small number of children and adults having their diagnosis of CF reversed. This article illustrates this issue with three cases. It considers how best to tell children and adults with their families, and the reactions that may be encountered. It also discusses practical issues of removing the diagnosis. 相似文献
9.
目的 系统评价益气活血法联合西药治疗特发性肺纤维化(idiopathic pulmonary fibrosis,IPF)的疗效及安全性。方法 系统检索中国知网、维普网、万方数据库、EMbase、PubMed、Cochrane Library图书馆等数据库,检索时限从数据库建库至2021年1月,纳入益气活血法联合西药治疗特发性肺纤维化的随机对照试验(randomized controlled trial,RCT),由2名研究人员独立筛选并交叉核对纳入结果,提取有效数据后,应用RevMan 5.3软件进行Meta分析。结果 纳入16项随机对照试验共计1160例IPF患者。分析结果显示益气活血法联合西药组可提高临床总有效率(OR= 3.71,95% CI [2.68,5.14],P<0.00001);改善患者肺功能:用力肺活量(MD=0.31,95% CI [0.23,0.38],P<0.00001)(MD=3.59,95% CI [1.51,5.66],P=0.0007),一氧化碳弥散量(MD=2.54,95% CI [1.83,3.25],P<0.00001);提高生活质量,降低圣乔治评分:呼吸困难(MD=-12.70,95% CI [-21.07,-4.32],P=0.003),活动能力(MD=-8.38,95% CI [-13.66,-3.10],P=0.002),疾病影响(MD=-13.87,95% CI [-22.53,-5.22],P=0.002);并可降低患者中医症状积分:喘息(MD=-0.66,95% CI [-0.84,-0.49],P<0.00001),咳嗽(MD=-0.71,95% CI [-1.04,-0.37],P<0.0001);有效提高动脉血氧分压(MD=5.92,95% CI [4.61,7.22],P<0.00001);且不增加不良事件发生率(OR=0.55,95% CI [0.27,1.14],P=0.11)。结论 益气活血法联合西药治疗IPF可提高临床治疗有效率,改善患者生活质量,且不增加临床不良事件(便秘、嗜睡、口干、恶心呕吐、皮肤瘙痒、腹泻等)发生率。但本研究纳入文献质量参差不齐,仍需更多大样本、高质量、多中心的RCT试验验证结论。 相似文献
10.
《Advances in medical sciences》2022,67(2):364-378
PurposeAlthough skin cutaneous melanoma (SKCM) is a relatively immunotherapy-sensitive tumor type, there is still a certain fraction that benefits less from treatment. Ferroptosis has been demonstrated to modulate tumor progression in many cancer types. This study focused on ferroptosis-related genes to construct a prognostic model for SKCM patients.Materials and methodsGene expression profiles of SKCM samples were obtained from public databases. Unsupervised consensus clustering was used to determine molecular subtypes related to ferroptosis. Least absolute shrinkage and selection operator (LASSO) and stepwise Akaike information criterion (stepAIC) were applied to construct a prognostic model based on differentially expressed genes between two molecular subtypes.ResultsC1 and C2 subtypes were identified with differential prognosis and immune infiltration. A 7-gene prognostic model was constructed to classify samples into high-FPRS and low-FPRS groups. Low-FPRS group with favorable prognosis had higher immune infiltration and more enriched immune-related pathways than the high-FPRS group. The two groups showed distinct sensitivity to immunotherapy, with the low-FPRS group predicted to have more positive response to immunotherapy than the high-FPRS group. A nomogram based on the FPRS score and clinical features was built for more convenient use.ConclusionsThe critical role of ferroptosis involved in SKCM development was further validated in this study. The prognostic model was efficient and stable to be applied in clinical conditions to support clinicians in determining personalized therapy for SKCM patients especially those with metastasis. 相似文献